Ephedrine Labeling MedWatch Reference Proposed In Texas
This article was originally published in The Tan Sheet
Executive Summary
Texas is considering amending its rules pertaining to ephedrine-containing dietary supplements sold in the state to require the toll-free number for FDA's MedWatch adverse event reporting program on product labels. This would be the first time the MedWatch number has been required on a product.
You may also be interested in...
Texas Ephedrine 18 AERs Too Few To Support MedWatch Proposal - AHPA
The "very small" number of adverse events reported in Texas related to ephedrine alkaloid-containing supplements suggests there is no public health risk, rendering proposed regs requiring the FDA MedWatch toll-free number on product labeling unnecessary, the American Herbal Products Association Ephedra Committee maintains.
Texas Ephedrine 18 AERs Too Few To Support MedWatch Proposal - AHPA
The "very small" number of adverse events reported in Texas related to ephedrine alkaloid-containing supplements suggests there is no public health risk, rendering proposed regs requiring the FDA MedWatch toll-free number on product labeling unnecessary, the American Herbal Products Association Ephedra Committee maintains.
Texas Ephedrine 18 AERs Too Few To Support MedWatch Proposal - AHPA
The "very small" number of adverse events reported in Texas related to ephedrine alkaloid-containing supplements suggests there is no public health risk, rendering proposed regs requiring the FDA MedWatch toll-free number on product labeling unnecessary, the American Herbal Products Association Ephedra Committee maintains.